David A Stradiotto

Title: David A Stradiotto: Innovator in Pharmaceutical Chemistry

Introduction

David A Stradiotto is a notable inventor based in Brantford, Canada. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 5 patents. His work focuses on the development of novel solid forms of pharmaceutical compounds, which are crucial for enhancing drug efficacy and stability.

Latest Patents

Among his latest patents, Stradiotto has developed a solid form of nilotinib hydrochloride. This innovative co-crystal consists of nilotinib hydrochloride and levulinic acid in a molar ratio of 1:2. The process for preparing this co-crystal is also detailed in his patent. Another significant patent involves atorvastatin calcium propylene glycol solvates. These solvates and the processes to prepare them are particularly useful for various pharmaceutical applications.

Career Highlights

Stradiotto has worked with prominent companies in the pharmaceutical industry, including Apotex Pharmachem Inc. and Apotex Inc. His experience in these organizations has allowed him to contribute to the development of important pharmaceutical products.

Collaborations

Throughout his career, Stradiotto has collaborated with esteemed colleagues such as Allan W Rey and Probal Kanti Datta. These collaborations have further enriched his research and innovation in the pharmaceutical field.

Conclusion

David A Stradiotto's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the development of effective pharmaceutical solutions.